Lidocaine on Pain Relief and IL and Substance P in Fibromyalgia
Condition(s):FibromyalgiaLast Updated:July 12, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):FibromyalgiaLast Updated:July 12, 2011Unknown status
Condition(s):Moderate to Severe Nasolabial FoldsLast Updated:July 20, 2022Completed
Condition(s):Adverse EffectsLast Updated:December 23, 2013Completed
Condition(s):Cardiovascular Diseases; Lidocaine Causing Adverse Effects in Therapeutic Use; Tracheal Intubation MorbidityLast Updated:October 9, 2017Completed
Condition(s):Acute Musculoskeletal Disease; Sprains; Sprains and Strains; Injuries; Emergencies; Trauma; Acute PainLast Updated:March 25, 2024Completed
Condition(s):Breast CancerLast Updated:October 22, 2020Unknown status
Condition(s):Myofascial Trigger Point Pain; Myofacial PainLast Updated:December 9, 2021Recruiting
Condition(s):Pain, PostoperativeLast Updated:September 25, 2018Completed
Condition(s):Urethra Issue; Pelvic Organ Prolapse; Urinary Incontinence; Vaginal Vault Prolapse; Cystocele; Uterine Prolapse; Vaginal Prolapse; Pelvic Floor DisordersLast Updated:August 1, 2023Completed
Condition(s):PainLast Updated:March 9, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.